The relevant disclosure is attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Malar Hospitals reported its Q1 FY26 results on August 4, 2025. Revenue from operations is zero, as the company had earlier sold its entire hospital business through a slump sale and currently has no business operations. Total income of about Rs 507 lakhs (standalone) came entirely from other income, which includes a one-time write-back of about Rs 408 lakhs from an old minimum wages provision following a Tamil Nadu government notification. The company posted a standalone profit after tax of Rs 417.65 lakhs (consolidated Rs 415.27 lakhs) and holds around Rs 3,232 lakhs in cash and bank balances, which management says is enough to meet ongoing obligations. Subsidiary Malar Stars Medicare has been converted into a Section 8 (non-profit) company. The board is said to be evaluating corporate restructuring options for the future since there is no plan to restart operations.
This is effectively a shell company with no operating revenue, relying on cash reserves and one-time reversals to show profits. Shareholders should watch for any corporate restructuring announcement from the board, as that could materially change the stock's direction. The large pending tax and legal demands (over Rs 25,000 lakhs in contingent liabilities) remain a key risk if the cash cushion gets used up.